Table 2 Serum levels of NGAL and NGAL/MMP9 in patients with acute/recurrent CSCR, chronic CSCR and healthy controls.

From: Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy

 

Acute/recurrent CSCRa (n = 71)

Chronic CSCRb (n = 76)

Healthy controlsc (n = 130)

p value*

NGAL serum level (ng/ml)

71.6 ± 33.4

89.9 ± 58.6

107.3 ± 44.5

a vs b : p = 0.006

a vs c : p < 0.001

b vs c : p < 0.001

NGAL/MMP9 serum level (ng /ml)

38.9 ± 38.4

54.8 ± 41.5

74.1 ± 42.6

a vs b : p = 0.002

a vs c : p < 0.001

b vs c : p < 0.001

  1. *Kruskal–Wallis test with post hoc Dunn test and Bonferroni correction.
  2. CSCR: central serous chorioretinopathy.
  3. NGAL: Neutrophil Gelatinase-Associated Lipocalin.
  4. MMP-9: Matrix metallopeptidase 9.
Back to article page